Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by StockingUp21on Jul 15, 2022 2:12pm
95 Views
Post# 34827593

RE:ATE Insider Trading

RE:ATE Insider Trading

put back the chart 2 qrtrs and overlay stock price. 


AND

Like I ask gamechange before disappearing add up all insider sales from 2.5 yrs ago and add up all insider buying since 2.5 years ago tell me the total.

I will never post again if you do this

 

davgro wrote: Now that I have the Dumpster back on IGNORE we can engage in some relevant ATE discussions.

There has been a lot of discussion recently about Insider Trades.  I grabbed a good chart that outlines ATE insider trades for the last 2 years.  Looking only at dollar values the insider trades have been insignificant other than a $300K sell in Q1 2021.  I personally see nothing positive or negative in recent ATE insider trades, or lack thereof.  Moving forward my focus is entirely on the science and I am optimistic that "long-term" my investment in ATE will pay off.

User image 

 

<< Previous
Bullboard Posts
Next >>